Senaste uppdateringen :
29/10/2024
Antimuskarint medel   Ipratropium bromide  
Aerosol
Stabilitet av läkemedel Stabilitet i blandningar Faktorer som påverkar stabiliteten Kompatibilitet Hänvisningar pdf
   Molekylstruktur  

Aerosol
Hänvisningar   Aerosol   Hänvisningar : Ipratropium bromide  
Typ Publikation
665 tidningen Blondino, FE, Baker M.
Stability of Nebulizer Admixtures.
Int J Pharm Compound 2005 ; 9, 4: 323-326.
2550 tidningen Roberts GW, Rossi S.O.P.
Compatibility of nebulizer solutions
Aust J Hosp Pharm 1993 ; 23: 35-37.
2635 tidningen Yamreudeewoh W, Teixeira G, Mayer GE.
Stability of levalbuterol in a mixture of levalbuterol and ipratropium nebulizer solution.
Hosp Pharm 2008 ; 43, 4: 303-306.
2685 tidningen Jacobson GA, Peterson GM.
Stability of ipratropium bromide and salbutamol nebuliser admixtures.
Int J Pharm Pract 1995 ; 3: 169-173.
2770 tidningen Krämer I, Schwabe A, Lichtinghagen R, Kamin W.
Physicochemical compatibility of nebulizable drug mixtures containing dornase alfa and ipratropium and/or albuterol.
Pharmazie 2007 ; 62, 10: 760-766.
2774 tidningen McKenzie J.E, Mario Cruz-Rivera M.
Compatibility of Budesonide Inhalation Suspension with Four Nebulizing Solutions.
Ann Pharmacotherapy 2004 ; 38: 967-972.
2787 tidningen Lee TY, Chen CM, Lee CN, Chaing YC.
Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium.
Am J Health-Syst Pharm 2005 ; 62, 8: 828-833.
2790 tidningen Kamin W, Schwabe A, Krämer I.
Physicochemical compatibility of fluconasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions.
Int J COPD 2007 ; 1, 4: 599-607.
2803 tidningen Bonasia PJ, McVicar WK, Williams B, Ong S.
Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium or acetylcysteine sodium.
Respiratory Care 2008 ; 683, 12: 1716-1722.
3019 tidningen Bonasia P, Cook C, Cheng Y et al.
Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs.
Curr Med Res Opin 2007 ; 23: 2477-2483.
3472 tidningen Krämer I, Schwabe A, Kamin W.
Physikalisch-chemische kompatilibität von Mischinhalationslösungen und suspensionen zur simultanen feuchtinhalationstherapie bei Mukoviszidose Patienten.
Krankenhauspharmazie 2007 ; 28, 5: 170-178.
3498 tidningen Akapo S, Gupta J, martinez E, Mccrea C, Ye L, Roach M
Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
Ann Pharmacotherapy 2008 ; 42, 10: 1416-1424.

  Mentions Légales